News
A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...
WHO includes ArkBio' paediatric RSV drug, ziresovir in PADO-RSV priority list: Shanghai, China Thursday, July 17, 2025, 14:00 Hrs [IST] Shanghai Ark Biopharmaceutical Co., Ltd. (A ...
Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others ...
Testing at India’s National Institute of Virology has confirmed a third recent Nipah virus case from India’s Kerla state, ...
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...
RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results